{"domain":"quantalx.com","status":"valid","tier":"listed","authority":46,"verified":false,"title":"QuantalX Neuroscience","summary":"QuantalX Neuroscience develops Delphi-MD™, an FDA De Novo-cleared, device-based","country":"US","country_source":"ip","publisher_country":null,"publisher_country_source":null,"hosting_country":"US","llms_txt":"https://www.quantalx.com/llms.txt","llms_full_txt":null,"last_checked":"2026-10-27T11:07:11.760Z","agent_terms":null,"categories":["healthcare"],"capabilities":[],"inferred_tags":["brain stimulation","neuroscience device","delphi-md","neurology","magnetic stimulation eeg"],"audience":"business","agent_uses":["read_docs"],"language":"en","platform_generated":false,"agent_summary":"QuantalX Neuroscience makes Delphi-MD, an FDA De Novo-cleared brain-network device for neurology and neurosurgery diagnosis.","llms_txt_cached":"https://agentwebmap.com/v1/domain/quantalx.com/llms.txt","agentic":"documentation","section_keys":["clinical-areas","contact","core-pages","evidence","for-patients-and-families","how-to-represent-quantalx-accurately","news","regulatory-and-reimbursement"],"section_partial":false,"section_indexed_at":"2026-10-25T23:49:06.242Z"}